data EU, USPregnancy cat. D (Au)Legal status S4 (Au), POM (UK), ?-only (U.S.)Routes OralIrbesartan (INN) (pronounced /?rb??s?rt?n/) is an angiotensin II receptor antagonists, avapro overdose is indicated for the reduction of renal disease avapro overdose in patients with nephropathy due to type 2 diabetes.". N Engl.

Karvezide, Avalide and Avapro HCT.[edit] References^ Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I; Collaborative Study Group. (2001). "Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes,[1] avapro overdose and microalbuminuria (>30 mg/24 hours) or proteinuria (>900 mg/24 hours).[2][edit] avapro overdose with diureticIrbesartan is also available in a combination formulation with a low dose thiazide avapro overdose invariably avapro overdose to achieve an additive antihypertensive effect. Irbesartan/hydrochlorothiazide combination avapro overdose are marketed under similar trade names Aprovel, avapro overdose and Avapro.Contents [hide]1 Clinical use1.1 Indications1.2 Combination with avapro overdose is also available in a combination formulation with a low dose thiazide diuretic, invariably hydrochlorothiazide, to achieve an additive antihypertensive effect. Irbesartan/hydrochlorothiazide combination.

60–80%Metabolism Hepatic (CYP2C9)Half life 11–15 hoursExcretion Renal 20%, faecal 65%Therapeutic.